Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-02-02 Sale | 2026-02-04 6:24 pm | Kiniksa Pharmaceuticals International plc | KNSA | Quart Barry D Director | 15,960 | $45.22 | $721,635 | 38,678 (Direct) | View |
| 2025-12-15 Sale | 2025-12-17 4:38 pm | Kiniksa Pharmaceuticals International plc | KNSA | Quart Barry D Director | 20,129 | $41.51 | $835,555 | 12,546 (Direct) | View |
| 2025-06-09 Sale | 2025-06-11 5:35 pm | Kiniksa Pharmaceuticals International plc | KNSA | Quart Barry D Director | 27,448 | $30.35 | $833,001 | 45,430 (Direct) | View |
| 2022-11-29 Sale | 2022-12-01 4:16 pm | Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director | 21,959 | $16.15 | $354,638 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-02 Exercise | 2026-02-04 6:24 pm | N/A 2029-05-28 | Kiniksa Pharmaceuticals International plc | KNSA | Quart Barry D Director | 15,960 | $0 | 38,678 (Direct) | View |
| 2026-02-02 Exercise | 2026-02-04 6:24 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Quart Barry D Director | 15,960 | $15.47 | 38,678 (Direct) | View |
| 2025-12-15 Exercise | 2025-12-17 4:38 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Quart Barry D Director | 20,129 | $10.36 | 12,546 (Direct) | View |
| 2025-12-15 Exercise | 2025-12-17 4:38 pm | N/A 2028-02-29 | Kiniksa Pharmaceuticals International plc | KNSA | Quart Barry D Director | 20,129 | $0 | 12,546 (Direct) | View |
| 2025-06-09 Exercise | 2025-06-11 5:35 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Quart Barry D Director | 27,448 | $3.8 | 45,430 (Direct) | View |
| 2025-06-09 Exercise | 2025-06-11 5:35 pm | N/A 2027-06-28 | Kiniksa Pharmaceuticals International plc | KNSA | Quart Barry D Director | 27,448 | $0 | 45,430 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-05 4:53 pm | N/A 2035-06-02 | Kiniksa Pharmaceuticals International plc | KNSA | Quart Barry D Director | 19,597 | $0 | 32,143 (Direct) | View |
| 2025-06-05 Exercise | 2025-06-05 4:53 pm | N/A N/A | Kiniksa Pharmaceuticals International plc | KNSA | Quart Barry D Director | 3,173 | $0 | 32,143 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:35 pm | N/A 2034-06-04 | Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director | 22,213 | $0 | 31,586 (Direct) | View |
| 2024-06-06 Exercise | 2024-06-07 4:35 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director | 4,373 | $0 | 31,586 (Direct) | View |
| 2023-06-29 Exercise | 2023-07-03 4:15 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director | 5,000 | $0 | 5,000 (Direct) | View |
| 2023-06-06 Option Award | 2023-06-08 4:21 pm | N/A 2033-06-05 | Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director | 30,609 | $0 | 30,609 (Direct) | View |
| 2023-01-18 Option Award | 2023-01-20 5:10 pm | N/A 2033-01-18 | HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer | 850,000 | $0 | 850,000 (Direct) | View |
| 2023-01-13 Tax Withholding | 2023-01-17 5:36 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer | 5,219 | $3.17 | 319,972 (Direct) | View |
| 2023-01-13 Exercise | 2023-01-17 5:36 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer | 19,767 | $0 | 319,972 (Direct) | View |
| 2022-10-31 Other | 2023-01-17 5:36 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer | 1,655 | $3.2725 | 319,972 (Direct) | View |
| 2022-11-29 Exercise | 2022-12-01 4:16 pm | N/A N/A | Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director | 21,959 | $1.59 | 0 (Direct) | View |
| 2022-11-29 Exercise | 2022-12-01 4:16 pm | N/A 2025-12-15 | Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director | 21,959 | $0 | 0 (Direct) | View |
| 2022-10-13 Tax Withholding | 2022-10-17 4:38 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer | 5,219 | $3.76 | 321,881 (Direct) | View |
| 2022-10-13 Exercise | 2022-10-17 4:38 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer | 19,768 | $0 | 321,881 (Direct) | View |
| 2022-07-13 Exercise | 2022-07-15 4:57 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer | 19,768 | $0 | 328,604 (Direct) | View |
| 2022-04-29 Other | 2022-07-15 4:57 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer | 1,504 | $3.842 | 328,604 (Direct) | View |
| 2022-07-13 Tax Withholding | 2022-07-15 4:57 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer | 5,219 | $3.01 | 328,604 (Direct) | View |
| 2022-06-29 Option Award | 2022-06-30 4:22 pm | N/A 2032-06-28 | Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director | 35,000 | $0 | 35,000 (Direct) | View |
| 2022-04-13 Tax Withholding | 2022-04-15 5:05 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer | 5,219 | $6.07 | 330,815 (Direct) | View |
| 2022-04-13 Exercise | 2022-04-15 5:05 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer | 19,768 | $0 | 330,815 (Direct) | View |
| 2022-01-13 Exercise | 2022-01-14 5:08 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer | 19,768 | $0 | 336,034 (Direct) | View |
| 2022-01-13 Tax Withholding | 2022-01-14 5:08 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer | 5,219 | $8.3 | 336,034 (Direct) | View |
| 2021-10-13 Option Award | 2021-10-15 4:25 pm | N/A 2031-10-13 | HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer | 586,251 | $0 | 732,087 (Direct) | View |
| 2021-10-13 Tax Withholding | 2021-10-15 4:25 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer | 963 | $10.55 | 732,087 (Direct) | View |
| 2021-10-13 Exercise | 2021-10-15 4:25 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer | 3,646 | $0 | 732,087 (Direct) | View |
| 2021-07-13 Tax Withholding | 2021-07-15 4:50 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer | 963 | $13.48 | 148,328 (Direct) | View |
| 2021-04-30 Other | 2021-07-15 4:50 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer | 1,529 | $13.9 | 148,328 (Direct) | View |
| 2021-07-13 Exercise | 2021-07-15 4:50 pm | N/A N/A | HERON THERAPEUTICS INC. | HRTX | Quart Barry D Chief Executive Officer | 3,645 | $0 | 148,328 (Direct) | View |
| 2021-06-29 Option Award | 2021-06-30 4:20 pm | N/A 2031-06-28 | Kiniksa Pharmaceuticals Ltd. | KNSA | Quart Barry D Director | 33,237 | $0 | 33,237 (Direct) | View |